250
Views
16
CrossRef citations to date
0
Altmetric
Editorial

Lipid-lowering agents and new onset diabetes mellitus

, , &
Pages 1965-1970 | Published online: 20 May 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Nazik Elmalaika OS Husain & Mohamed H Ahmed. (2015) Managing dyslipidemia in HIV/AIDS patients: challenges and solutions. HIV/AIDS - Research and Palliative Care 7, pages 1-10.
Read now
Nazik Elmalaika Husain, Abdallah Tarig Hassan, Wadie M Elmadhoun & Mohamed H Ahmed. (2015) Evaluating the safety of Liptruzet (ezetimibe and atorvastatin): what are the potential benefits beyond low-density lipoprotein cholesterol-lowering effect?. Expert Opinion on Drug Safety 14:9, pages 1445-1455.
Read now
Vasilios G. Athyros, Niki Katsiki, Asterios Karagiannis & Dimitri P. Mikhailidis. (2014) The 2013 American College of Cardiology/American Heart Association guidelines for the treatment of dyslipidemia: mind the gaps!. Current Medical Research and Opinion 30:9, pages 1701-1705.
Read now
Mohamed H Ahmed, Ayman Al-Atta & Mahir A Hamad. (2012) The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges. Expert Opinion on Pharmacotherapy 13:13, pages 1901-1909.
Read now
Niki Katsiki1 & Maciej Banach. (2012) Statin use and risk of diabetes mellitus in postmenopausal women. Clinical Lipidology 7:3, pages 267-270.
Read now
Vasilios G. Athyros, Konstantinos Tziomalos, Georgios N. Daskalopoulos, Asterios Karagiannis & Dimitri P. Mikhailidis. (2011) Statin-based treatment for cardiovascular risk and non-alcoholic fatty liver disease. Killing two birds with one stone?. Annals of Medicine 43:3, pages 167-171.
Read now
Niki Katsiki, Dimitri P Mikhailidis, Anna Gotzamani-Psarrakou, John G Yovos & Dimitrios Karamitsos. (2011) Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus. Expert Opinion on Therapeutic Targets 15:4, pages 401-420.
Read now
Sydney B Long, Michael J Blaha, Roger S Blumenthal & Erin D Michos. (2011) Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly. Clinical Interventions in Aging 6, pages 27-35.
Read now
Dick C Chan & Gerald F Watts. (2011) Dyslipidaemia in the metabolic syndrome and type 2 diabetes: pathogenesis, priorities, pharmacotherapies. Expert Opinion on Pharmacotherapy 12:1, pages 13-30.
Read now
Maria Sarigianni, Niki Katsiki & Dimitri P Mikhailidis. (2010) Ezetimibe in diabetes: more than cholesterol lowering?. Current Medical Research and Opinion 26:10, pages 2517-2520.
Read now

Articles from other publishers (6)

Yinghua Ma, Jianyu Xiong, Xueting Zhang, Tongtong Qiu, Huai Pang, Xue Li, Jiaojiao Zhu, Jingzhou Wang, Chongge Pan, Xin Yang, Xiaolong Chu, Bingqi Yang, Cuizhe Wang & Jun Zhang. (2020) Potential biomarker in serum for predicting susceptibility to type 2 diabetes mellitus: Free fatty acid 22:6. Journal of Diabetes Investigation 12:6, pages 950-962.
Crossref
Panagiotis Anagnostis, Fotini Adamidou, Aristidis Slavakis, Stergios A Polyzos, Despina Selalmatzidou, Athanasios Panagiotou, Vasilios G Athyros, Asterios Karagiannis & Marina Kita. (2014) Comparative Effect of Atorvastatin and Rosuvastatin on 25-hydroxy-Vitamin D Levels in Non-diabetic Patients with Dyslipidaemia: A Prospective Randomized Open-label Pilot Study. The Open Cardiovascular Medicine Journal 8:1, pages 55-60.
Crossref
Vassilios G. Athyros, Moses S. Elisaf, Theodore Alexandrides, Apostolos Achimastos, Emmanouel Ganotakis, Eleni Bilianou, Asterios Karagiannis, Evangelos N. Liberopoulos, Konstantinos Tziomalos & Dimitri P. Mikhailidis. (2011) Long-Term Impact of Multifactorial Treatment on New-Onset Diabetes and Related Cardiovascular Events in Metabolic Syndrome. Angiology 63:5, pages 358-366.
Crossref
Vassilios G. Athyros & Dimitri P. Mikhailidis. (2012) Statins and new-onset diabetes mellitus—a matter for debate. Nature Reviews Endocrinology 8:3, pages 133-134.
Crossref
P. Anagnostis, D. Selalmatzidou, S. A. Polyzos, A. Panagiotou, A. Slavakis, A. Panagiotidou, V. G. Athyros, A. Karagiannis, D. P. Mikhailidis & M. Kita. (2011) Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study. International Journal of Clinical Practice 65:6, pages 679-683.
Crossref
Jocelyne G. Karam & Samy I. McFarlane. (2010) Update on the Prevention of Type 2 Diabetes. Current Diabetes Reports 11:1, pages 56-63.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.